Xylutide 40 mg capsules (containing Enzalutamide) are oral, high-affinity androgen receptor inhibitors used to treat advanced prostate cancer by blocking testosterone from binding to cancer cells. It suppresses tumor growth, causes apoptosis, and is used for metastatic castration-resistant prostate cancer (mCRPC).